The shortage of Cisplatin and Carboplatin in India shows how geopolitical conflicts can disrupt global pharmaceutical supply ...

The MarketWatch News Department was not involved in the creation of this content. The global industry was valued at US$ 38.9 Bn in 2022 and is expected to register a CAGR of 7.1% from 2023 to 2031.

Dublin, April 30, 2026 (GLOBE NEWSWIRE)-- The "Pharmaceutical API Manufacturing Market Report 2026" has been added to ResearchAndMarkets.com's offering. The pharmaceutical API manufacturing market has ...

With the COVID-19 pandemic nearing its second year in the U.S., lawmakers have banged the drum on boosting "onshore" production of key pharmaceuticals and ingredients to ensure supply-side security.

Goldman Sachs reports the future of semaglutide genericisation and GLP-1 pricing hinges on peptide API manufacturing capacity ...

MISSISSAUGA, Ontario, April 16, 2026--(BUSINESS WIRE)--Eurofins CDMO Alphora is excited to announce the expansion of its Active Pharmaceutical Ingredient (API) manufacturing capabilities through the ...

The big unknown is whether CDMO capacity built for branded drugs gets diverted to generics, and whether SPPS can scale fast ...

Axplora is strategically consolidating ursodeoxycholic acid (UDCA) manufacturing at its Vizag, India site, part of the ...

Amazon Filters is a leading manufacturer of bespoke filter housings and high-performance filter media used in the manufacture of Active Pharmaceutical Ingredients (API's) - vital building blocks for ...

What not to do with active pharmaceutical ingredient (API) batch records? Tear them out of a company logbook ahead of an FDA inspection, for one. Earlier this month, Indian drugmaker Indiana Chem-Port ...